Evaluating the safety of the SNOO Smart Sleeper for high-risk infants
Official title: The Happiest Baby, Inc. SNOO Postmarket Surveillance Study
Run by Happiest Baby, Inc. · NCT06361303 · Data updated 2026-11-12
This study is trying to see if the SNOO Smart Sleeper is safe for high-risk infants by checking in with caregivers about any serious injuries or deaths over six months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1900 (estimated) |
| Sponsor | Happiest Baby, Inc. Industry-sponsored |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | November 29, 2023 |
| Main results expected | January 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT06361303 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include primary caregivers of infants who are at high risk for SUID and have purchased or rented a SNOO Bassinet.
✕Probably not a fit
Patients who do not meet the high-risk criteria for SUID or are not primary caregivers will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study assesses the safety of the SNOO Smart Sleeper Bassinet for infants at high risk for Sudden Unexpected Infant Death (SUID). It involves surveying 1000 caregivers of these infants to track the occurrence of serious injuries or deaths associated with the use of the SNOO. Participants will complete an electronic eligibility screening and follow-up surveys to report any adverse events over a six-month period. The study aims to gather data on usage patterns and outcomes related to the device.
Why it matters
Potential benefit: If successful, this study could provide critical safety data that may enhance the use of the SNOO Bassinet for protecting high-risk infants.
How similar studies have gone: While this study focuses on postmarket surveillance, similar studies evaluating infant sleep safety devices have shown promising results in improving safety outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Infant/caregiver dyads meeting the following inclusion criteria will be eligible for study enrollment: * Respondent must identify as a primary caregiver of the infant. * Purchase or rental of SNOO shipped to a U.S. residence during the defined enrollment period. * Caregivers must be English speakers ages 18 or older residing in the United States. * Infants must use SNOO during the intended use period (i.e., birth to 6 months). * Infants must meet at least one of the following criteria for high risk for SUID: * Infant race: Black or African American; and/or American Indian or Alaskan Native * Maternal education: 12 years or less * Low birth weight: \<5 pounds 8 ounces (\<2500 grams) * Last menstrual cycle (LMP) or obstetrical estimate (OE) Gestational age at time of birth: \<37 weeks (preterm) * Maternal age at time of birth: \<25 years * Smoking status: Any self-reported maternal smoking during pregnancy Exclusion Criteria: * Not primary caregiver * Does not speak English * Is not a US resident * Is not 18 years old or older * Infant did not use SNOO during the intended use period (i.e., birth to 6 months). * Infants does NOT meet at least one of the below risk criteria: * Infant race: Black or African American; and/or American Indian or Alaskan Native * Maternal education: 12 years or less * Low birth weight: \<5 pounds 8 ounces (\<2500 grams) * LMP or OE Gestational age at time of birth: \<37 weeks (preterm) * Maternal age at time of birth: \<25 years * Smoking status: Any self-reported maternal smoking during pregnancy
Where it's running
-
Happiest Baby, Inc.
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Christopher Laine, PhD — Happiest Baby, Inc.
- Study coordinator: Christopher Laine, PhD
- Email: christopher@happiestbaby.com
- Phone: 310-476-9358
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Walk With Me for Perinatal Grief
A mobile app-based program (Along With Me) with or without a Peer Guide is tested to see if it lowers posttraumatic stress and suicidal thoughts in bereaved parents after pregnancy or early infant loss.
-
Monitoring vital signs of newborns using advanced wireless sensors
This study is testing a new wireless sensor to see if it can safely and accurately monitor the vital signs of healthy newborns during their first two hours after birth compared to the traditional wired system.
-
TodaysBaby mobile safe-sleep support for new parents
This program tests the TodaysBaby mobile safe-sleep messaging for parents of healthy, full-term newborns to see if it improves safe sleep practices and reaches families equally across income and race/ethnicity.
-
Improving HIV testing and treatment for mothers and newborns in Tanzania and Mozambique
This study is trying to improve HIV testing and treatment for mothers and their newborns in Tanzania and Mozambique to help prevent the virus from passing from mother to child.
-
Comparing umbilical cord milking and early cord clamping for preterm infants
This study is testing if milking the umbilical cord instead of clamping it right away can help save the lives of preterm babies born between 30 and 34 weeks who need immediate care.
-
Using online social networks to promote safe infant care practices
This study is trying to see if private Facebook groups can help pregnant women and new parents follow safe sleep guidelines and improve breastfeeding by providing them with helpful information and support from others.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.